Euro-Med Laboratories Phil., Inc. (EURO) Stock Price

Data as of: 21-Jan-2025 Tue 3:30 PM / (Last Trading)
1.28%
Trading Data
₱0.790
₱0.780 - ₱0.790
₱0.710 - ₱0.920
₱790
1,000
Valuation Metrics
₱3.25 Billion
39.50
₱0.0200
₱1.45
-

The stock price of EURO today is ₱0.790, based on the most recent trading session. EURO share price increased by 1.28% (see other notable gainers), with a trading volume of 1,000 shares.

Price Data by Timeframe

The table below provides a snapshot of the stock's performance over various timeframes.

Period % Change Average Price Highest Price Lowest Price Average Volume Average Trade
7 Days 1.28% ₱0.770 ₱0.790 ₱0.720 23,400 shares ₱17,908
1 Month -11.24% ₱0.820 ₱0.890 ₱0.720 30,882 shares ₱25,262
3 Months 0% ₱0.840 ₱0.920 ₱0.720 64,793 shares ₱56,861
6 Months 1.28% ₱0.790 ₱0.920 ₱0.710 48,908 shares ₱40,420
YTD -3.66% ₱0.810 ₱0.880 ₱0.720 29,429 shares ₱23,721
1 Year 1.28% ₱0.770 ₱0.920 ₱0.710 28,946 shares ₱23,610


EURO Stock Information
Sector
Industrial
Subsector
Chemicals
Outstanding Shares
4,112,140,540
Share Type
Common
Listing Date
Jul 02, 1998
ISIN
PHY2352T1098
1000
Company Profile
Euro-Med Laboratories Philippines, Inc. (EURO) was incorporated and registered with the Securities and Exchange Commission on January 29, 1988. Upon receipt of the licenses and product registration approvals from the Food and Drug Administration Philippines, EURO began commercial production in 1991.EURO is engaged in the manufacture of pharmaceutical products such as large and small volume parenteral and other solutions. The Company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation and dialysis. EURO is likewise engaged in the toll manufacturing of pharmaceutical products in liquid form.The Company's subsidiaries are Hemotek Renal Center, Inc., which is engaged as a dialysis center; and CafeFrance Corp., which is engaged to operate restaurants, bakeries, food services, catering, food production, and other related services.Source: SEC Form 17-A (2023)